ADR
Global Drug Safety and Risk Management
May 06 by Elie MagdalaniReported adverse events are an important tool for implementing a risk management program. An important contributing factor in the evolved AEs the condition of chronically ill patients taking a drug da...
Pharmacovigilance is Not Just About Compliance
March 23 by Andrea CharlesDr. Viraj Suvarna, Medical Director and Head of Medical Affairs at Boehringer Ingelheim, joins Andrea Charles from Pharma IQ to discuss the importance of training and re-training field operatives to r...
Would ASEAN Accept Data and Reviews that Cross Borders?
August 11 by Bryan CamoensRobert Lim, Head of Haematology and Oncology, for the National University Cancer Institute, speaks exclusively to Bryan Camoens from Pharma IQ, on the fundamental difference between pharmacodili...
Pharmacovigilance in Asia: Will China One Day Take the Lead?
July 29 by Bryan CamoensJean Christophe Delumeau, Head of Pharmacovigilance Asia-Pacific for Bayer Healthcare Global R&D Centre, speaks exclusively to Bryan Camoens from Pharma IQ, on the evolution of Pharmacovigilance...